dc.contributor.author | Ergül D.F. | |
dc.contributor.author | Boran M. | |
dc.date.accessioned | 2024-03-12T19:35:52Z | |
dc.date.available | 2024-03-12T19:35:52Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 13094483 | |
dc.identifier.uri | https://doi.org/10.52142/omujecm.39.2.51 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12450/3011 | |
dc.description.abstract | The recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease.In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature. © 2022 Ondokuz Mayis Universitesi. All rights reserved. | en_US |
dc.description.sponsorship | DURSUN FIRAT ERGÜL-2021-06-02T11_51_11 | en_US |
dc.description.sponsorship | The patient provided informed consent for the publication of this case. In accordance with the provisions of the Ministry of Health of the Republic of Turkey, the ethics committee of the Ministry of Health was applied and approval was obtained with the number DURSUN FIRAT ERGÜL-2021-06-02T11_51_11. Attached is the e-mail printout showing that it was accepted. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Ondokuz Mayis Universitesi | en_US |
dc.relation.ispartof | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | acute respiratory distress syndrome | en_US |
dc.subject | covid-19-associated pulmonary aspergillosis | en_US |
dc.subject | pulmonary aspergillosis | en_US |
dc.subject | steroid treatment | en_US |
dc.subject | anakinra | en_US |
dc.subject | budesonide | en_US |
dc.subject | C reactive protein | en_US |
dc.subject | enoxaparin | en_US |
dc.subject | ferritin | en_US |
dc.subject | fibrinogen | en_US |
dc.subject | lactic acid | en_US |
dc.subject | lansoprazole | en_US |
dc.subject | methylprednisolone | en_US |
dc.subject | midazolam | en_US |
dc.subject | moxifloxacin | en_US |
dc.subject | oxygen | en_US |
dc.subject | piperacillin plus tazobactam | en_US |
dc.subject | procalcitonin | en_US |
dc.subject | rocuronium | en_US |
dc.subject | voriconazole | en_US |
dc.subject | adult | en_US |
dc.subject | adult respiratory distress syndrome | en_US |
dc.subject | antibiotic therapy | en_US |
dc.subject | Article | en_US |
dc.subject | asthma | en_US |
dc.subject | atelectasis | en_US |
dc.subject | blood pressure | en_US |
dc.subject | breathing rate | en_US |
dc.subject | bronchoscopy | en_US |
dc.subject | carbon dioxide tension | en_US |
dc.subject | case report | en_US |
dc.subject | clinical article | en_US |
dc.subject | computer assisted tomography | en_US |
dc.subject | coronavirus disease 2019 | en_US |
dc.subject | extubation | en_US |
dc.subject | fever | en_US |
dc.subject | follow up | en_US |
dc.subject | Glasgow coma scale | en_US |
dc.subject | high flow nasal cannula therapy | en_US |
dc.subject | hospitalization | en_US |
dc.subject | human | en_US |
dc.subject | intubation | en_US |
dc.subject | laboratory test | en_US |
dc.subject | lavage fluid | en_US |
dc.subject | left ventricular apex | en_US |
dc.subject | leukocyte count | en_US |
dc.subject | lung aspergillosis | en_US |
dc.subject | lymphocyte count | en_US |
dc.subject | male | en_US |
dc.subject | medical history | en_US |
dc.subject | middle aged | en_US |
dc.subject | neutrophil count | en_US |
dc.subject | noninvasive ventilation | en_US |
dc.subject | platelet count | en_US |
dc.subject | pneumothorax | en_US |
dc.subject | polymerase chain reaction | en_US |
dc.subject | protein blood level | en_US |
dc.subject | respiratory distress | en_US |
dc.subject | sedation | en_US |
dc.subject | sedimentation rate | en_US |
dc.subject | synchronized intermittent mandatory ventilation | en_US |
dc.subject | tachypnea | en_US |
dc.subject | tracheostomy | en_US |
dc.title | A case report: Successful management of pulmonary aspergillosis associated with COVID ? 19 ARDS | en_US |
dc.type | article | en_US |
dc.department | Amasya Üniversitesi | en_US |
dc.identifier.volume | 39 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 563 | en_US |
dc.identifier.endpage | 565 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopus | 2-s2.0-85142013909 | en_US |
dc.identifier.doi | 10.52142/omujecm.39.2.51 | |
dc.department-temp | Ergül, D.F., Department of Intensive Care, University of Amasya, Sabuncuoğlu Şerafeddin Training and Research Hospital, Amasya, Turkey; Boran, M., Department of Intensive Care, University of Amasya, Sabuncuoğlu Şerafeddin Training and Research Hospital, Amasya, Turkey | en_US |
dc.authorscopusid | 56638585800 | |
dc.authorscopusid | 57217935893 | |